UBS Group AG

SEC CIK: 0001610520
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

CURX holding history

Curanex Pharmaceuticals Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CURX overview All 13F holders of CURX Full Q2 2026 holdings

Shares (Q2 2026): 1,506
Value: $400
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of CURX by UBS Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,506	$400	<0.1%	−6,489−81.2%	Reduced	Holders
Q1 2026	7,995	$4.08K	<0.1%	−4,996−38.5%	Reduced	Holders
Q4 2025	12,991	$4.30K	<0.1%	−51,525−79.9%	Reduced	Holders
Q3 2025	64,516	$46.5K	<0.1%	+64,516	New	Holders